Show simple item record

dc.contributor.authorEden, Tim O B
dc.contributor.authorBirch, Jillian M
dc.contributor.authorBruce, J
dc.contributor.authorCampbell, Richard H A
dc.contributor.authorGattamaneni, Rao
dc.contributor.authorJenney, M E
dc.contributor.authorJones, E
dc.contributor.authorKelsey, Anna M
dc.contributor.authorLashford, Linda S
dc.contributor.authorStevens, Richard F
dc.contributor.authorWill, A
dc.date.accessioned2010-03-23T14:39:52Z
dc.date.available2010-03-23T14:39:52Z
dc.date.issued1997
dc.identifier.citationPediatric oncology and hematology in Manchester, England., 14 (3):191-7 Pediatr Hematol Oncolen
dc.identifier.issn0888-0018
dc.identifier.pmid9185203
dc.identifier.doi10.3109/08880019709009488
dc.identifier.urihttp://hdl.handle.net/10541/94684
dc.description.abstractThe Manchester pediatric oncology unit is the third largest unit in the United Kingdom, with approximately 120 new referred cases per annum (10% of the U.K. total). Research activities include a gene therapy program, peripheral blood stem cell studies, the genetic epidemiology of childhood cancer, late-effects research (growth, body composition, pulmonary, quality of life), psychosocial studies, and clinical trial organization. Both the clinical oncology service and research activities involve close team coordination and collaboration with scientists both within and outside Manchester. A comprehensive pediatric hematology service is provided. The unit contains the second largest children's hemophilia service in the United Kingdom, serving 200 patients with congenital blood disorders. Twenty-five bone marrow transplants are performed each year (allogeneic, unrelated donor, autologous, and peripheral stem cell) for malignant and nonmalignant disorders. These activities are closely related to local, national, and international research groups.
dc.language.isoenen
dc.subjectCanceren
dc.subjectHaematologic Diseasesen
dc.subject.meshChild
dc.subject.meshChild Health Services
dc.subject.meshChild, Preschool
dc.subject.meshEngland
dc.subject.meshFemale
dc.subject.meshHematologic Diseases
dc.subject.meshHumans
dc.subject.meshInfant
dc.subject.meshMale
dc.subject.meshNeoplasms
dc.titlePediatric oncology and hematology in Manchester, England.en
dc.typeArticleen
dc.contributor.departmentDepartment of Paediatric Oncology, Royal Manchester Children's Hospitals Trusts, UK.en
dc.identifier.journalPediatric Hematology and Oncologyen
html.description.abstractThe Manchester pediatric oncology unit is the third largest unit in the United Kingdom, with approximately 120 new referred cases per annum (10% of the U.K. total). Research activities include a gene therapy program, peripheral blood stem cell studies, the genetic epidemiology of childhood cancer, late-effects research (growth, body composition, pulmonary, quality of life), psychosocial studies, and clinical trial organization. Both the clinical oncology service and research activities involve close team coordination and collaboration with scientists both within and outside Manchester. A comprehensive pediatric hematology service is provided. The unit contains the second largest children's hemophilia service in the United Kingdom, serving 200 patients with congenital blood disorders. Twenty-five bone marrow transplants are performed each year (allogeneic, unrelated donor, autologous, and peripheral stem cell) for malignant and nonmalignant disorders. These activities are closely related to local, national, and international research groups.


This item appears in the following Collection(s)

Show simple item record